Holen Sie sich die Stockscreener-App
9.115
0.05%
0.045
Schlusskurs vom Vortag:
$9.16
Offen:
$9.28
24-Stunden-Volumen:
483.86K
Relative Volume:
0.09
Marktkapitalisierung:
$2.12B
Einnahmen:
$509.86M
Nettoeinkommen (Verlust:
$165.35M
KGV:
13.45
EPS:
0.6779
Netto-Cashflow:
$107.55M
1W Leistung:
+9.50%
1M Leistung:
+14.99%
6M Leistung:
-51.30%
1J Leistung:
-48.74%
1-Tages-Spanne:
$9.045
$9.31
1-Wochen-Bereich:
$8.52
$9.31
52-Wochen-Spanne:
$7.2101
$20.46
Adma Biologics Inc Stock (ADMA) Company Profile
Firmenname
Adma Biologics Inc
Sektor
Branche
Telefon
(201) 478-5552
Adresse
C/O ADMA BIOLOGICS, INC., RAMSEY
Compare ADMA vs VRTX, REGN, ARGX, ALNY, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ADMA
Adma Biologics Inc
|
9.1534 | 2.07B | 509.86M | 165.35M | 107.55M | 0.6779 |
VRTX
Vertex Pharmaceuticals Inc
|
519.60 | 134.02B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
669.30 | 68.59B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
925.45 | 58.44B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
319.66 | 41.76B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
190.15 | 40.23B | 742.00K | -1.37B | -1.07B | -7.0731 |
Adma Biologics Inc Stock (ADMA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-21 | Eingeleitet | Canaccord Genuity | Buy |
| 2026-03-26 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2023-07-19 | Fortgesetzt | Raymond James | Strong Buy |
| 2022-10-13 | Eingeleitet | Mizuho | Buy |
| 2021-11-11 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2021-11-09 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-06-04 | Eingeleitet | Jefferies | Buy |
| 2019-04-15 | Bestätigt | H.C. Wainwright | Buy |
| 2019-02-07 | Fortgesetzt | H.C. Wainwright | Buy |
| 2017-12-11 | Bestätigt | Maxim Group | Buy |
| 2017-11-14 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2017-01-23 | Hochstufung | Maxim Group | Hold → Buy |
| 2016-08-01 | Herabstufung | Maxim Group | Buy → Hold |
| 2016-07-25 | Bestätigt | Maxim Group | Buy |
| 2015-05-13 | Bestätigt | Maxim Group | Buy |
| 2014-12-08 | Eingeleitet | Oppenheimer | Outperform |
| 2014-12-01 | Bestätigt | Maxim Group | Buy |
Alle ansehen
Adma Biologics Inc Aktie (ADMA) Neueste Nachrichten
ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Nano-X Imaging Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action – NNOX - GlobeNewswire Inc.
ADMA Biologics, Inc. (ADMA) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
ADMA Biologics, Inc. Class Action Lawsuit Seeks Recovery - GlobeNewswire
ADMA DEADLINE: Levi & Korsinsky Reminds ADMA BIOLOGICS, INC. Investors of Upcoming Securities Class Action Deadline - PR Newswire
ADMA BIOLOGICS, INC. INVESTORS WITH LOSSES HAVE UNTIL - GlobeNewswire
ADMA Stock Downgraded By Cantor As ‘Channel Stuffing’ Claims Shake Investor Confidence - Stocktwits
ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - GlobeNewswire Inc.
ADMA Faruqi & Faruqi, LLP Reminds ADMA Biologics Investors of Securities Class Action Lawsuit Deadline on August 10, 2026 - marketscreener.com
ADMA Tumbles On Slashed Outlook As Short-Seller Aftermath Meets Competitive Headwinds - Stocktwits
Trading Systems Reacting to (ADMA) Volatility - Stock Traders Daily
ADMA Investors Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit with the Schall Law Firm - GlobeNewswire
ADMA Biologics (NASDAQ: ADMA) Investigated for Potential - GlobeNewswire
ADMA Biologics, Inc. (ADMA) Investigation: Bronstein, Gewirtz & G - The National Law Review
$ADMA Notification: ADMA Biologics Accused of Misrepresentations about its Revenue Sources in Securities Fraud Class Action - TradingView
Adma Biologics (ADMA) Stock Falls Amid Market Uptick: What Investors Need to Know - Yahoo! Finance Canada
ADMA BIOLOGICS, INC. INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates ADMA Biologics, Inc.’s Directors and Officers for Breach of Fiduciary Duties – ADMA - Business Wire
ROSEN, SKILLED INVESTOR COUNSEL, Encourages ADMA Biologics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the FirmADMA - TMX Newsfile
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff - GlobeNewswire
Lead Plaintiff Deadlines in Shareholder Class Action - GlobeNewswire
Investor Announcement: ADMA Biologics Investors are Notified to Contact BFA Law about the Pending Securities Fraud Class Action to Recover Stock Losses - GlobeNewswire
ADMA Biologics, Inc.(NasdaqGM: ADMA) added to Russell 2000 Growth-Defensive Index - marketscreener.com
ADMA Biologics, Inc. (ADMA) Class Action Lawsuit Seeks Recovery for Investors; August 10, 2026, DeadlineContact Kessler Topaz Meltzer & Check, LLP - NewMediaWire
ADMA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that ADMA Biologics, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
ADMA Biologics Faces Securities Fraud Class Action Lawsuit - Intellectia AI
ADMA Biologics, Inc. Actuals & Estimates (NASDAQ:ADMA) - TradingView
Kessler Topaz Meltzer & Check, LLP - GlobeNewswire Inc.
Did You Lose Money on ADMA Biologics, Inc. (ADMA)? Levi & Korsinsky Urges Investors to Act Before August 10, 2026 - ACCESS Newswire
Levi & Korsinsky Urges ADMA Biologics, Inc. (ADMA) Shareholders to Act Before Lead Plaintiff Deadline August 10, 2026 - ACCESS Newswire
ADMA Biologics, Inc. Actuals & Estimates (BX:ADMA) - TradingView
Levi & Korsinsky Notifies ADMA Biologics, Inc. (ADMA) Shareholders of Class Action Lawsuit and August 10, 2026 Deadline - ACCESS Newswire
ADMA Biologics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against ADMA Biologics, Inc.ADMA - PR Newswire
ADMA SHAREHOLDER ALERT: Securities Fraud Lawsuit Filed on Behalf of ADMA Biologics, Inc. Investors - GlobeNewswire Inc.
ADMA Investors Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firm - The Keene Sentinel
Class Action Lawsuit Filed Against ADMA Biologics, Inc. (ADMA)Recover LossesContact Levi & Korsinsky Before August 10, 2026 - ACCESS Newswire
ADMA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that ADMA Biologics, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Deadline Alert: ADMA Biologics, Inc. (ADMA) Shareholders - GlobeNewswire
DEADLINE ALERT for VIA, Z, and ADMA: The Law Offices of - GlobeNewswire
ADMA Shareholder Alert: ADMA Biologics, Inc. Securities - GlobeNewswire
ADMA Biologics, Inc. (ADMA) Investors: August 10, 2026, Deadline in Securities Fraud Class Action Lawsuit - The Globe and Mail
ADMA Biologics Inc (ADMA) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
ADMA Biologics, Inc. Actuals & Estimates (BOATS:ADMA) - TradingView
Price to earnings forward of ADMA Biologics Inc – NASDAQ:ADMA - TradingView
Enterprise value to revenue forward of ADMA Biologics Inc – NASDAQ:ADMA - TradingView
What Are the Allegations Against ADMA Biologics - Kavout | AI
ADMA LAWSUIT ALERT: Levi & Korsinsky Notifies ADMA Biologics, Inc. InvestorsLead Plaintiff Deadline August 10, 2026 - ACCESS Newswire
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages ADMA Biologics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by The FirmADMA - ACCESS Newswire
Contact Levi & Korsinsky by August 10, 2026 to Join Class Action Against ADMA Biologics, Inc. (ADMA) - ACCESS Newswire
Class Action Lawsuit Alert: Levi & Korsinsky Reminds ADMA Biologics, Inc. (ADMA) Investors of August 10, 2026 Deadline - ACCESS Newswire
Enterprise value to EBITDA forward of ADMA Biologics Inc – NASDAQ:ADMA - TradingView
Lost Money on ADMA Biologics, Inc. (ADMA)? Contact Levi & Korsinsky Before August 10, 2026 to Join Class Action - ACCESS Newswire
ROSEN, THE FIRST FILING FIRM, Encourages ADMA Biologics, Inc. Investors to Secure Counsel ... - Caledonian Record
Finanzdaten der Adma Biologics Inc-Aktie (ADMA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Adma Biologics Inc-Aktie (ADMA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Grossman Jerrold B | Director |
May 12 '26 |
Buy |
8.01 |
12,500 |
100,125 |
513,884 |
| Grossman Jerrold B | Director |
May 11 '26 |
Buy |
8.01 |
12,500 |
100,125 |
501,384 |
| Guiheen Lawrence P. | Director |
Mar 13 '26 |
Option Exercise |
3.66 |
30,000 |
109,800 |
135,520 |
| Grossman Adam S | President and CEO |
Mar 16 '26 |
Option Exercise |
5.40 |
15,000 |
81,000 |
2,133,777 |
| Grossman Adam S | President and CEO |
Mar 16 '26 |
Sale |
15.16 |
21,000 |
318,360 |
2,112,777 |
0.82%
0.85%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):